The average Medicare payment for a person with Alzheimer’s or other dementias is roughly three times higher than patients without those conditions. Medicaid payments are 19 times higher.
By 2050, the Alzheimer’s Association estimated the healthcare costs of Alzheimer’s, the sixth-leading cause of death in the United States, will be $1.1 trillion, which includes a 500 percent increase in combined Medicare and Medicaid spending.
More Articles on Hospital Neurology:
Study: Stroke Hospitalization Costs Driven by Neuroimaging
7 Ways to Enhance a Hospital Neurosurgery Department
HHS Releases Draft of National Plan to Fight Alzheimer’s Disease
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit